Vita Gazette

News from Italy

Mycoplasma pneumonia has arrived in Italy

Vita Gazette – There were two cases of mycoplasma pneumonia in children in Italy. Various outbreaks have already been recorded in China, where the bacterium was initially reported.

Two cases of Mycoplasma pneumoniae pneumonia in hospitalised children with respiratory symptoms were reported in Italy by the reference laboratory of Perugia. One of the cases relates to week 47 of 2023 and is coinfection with Rhinovirus, while the other concerns the current week and the data is in line with what is expected in this period. The RespiVirNet surveillance bulletins of the Higher Institute of Health highlight this.

However, their conditions do not cause concern. One has already been discharged, and the other will be discharged in the next few days, reported the Santa Maria della Misericordia. Professor Alberto Verrotti, director of the complex paediatrics structure, specified, “A child has recovered and has already returned to his home without any complications. The second suffering from pneumonia is still under antibiotic therapy, already fever-free, and has a favourable outcome. In the latter case, the real cause of the pneumonia was the streptococcus pyogenes infection, and the mycoplasma pneumonia infection was a simple temporal coincidence. Mycoplasma pneumoniae is a bacterium that commonly causes respiratory tract infections in children with a favourable outcome because it responds rapidly to antibiotic therapy.”

“We are monitoring the situation in China, and once again, we have seen an overall increase in acute respiratory infections due to several different pathogens, including influenza, which is on the rise. Mycoplasma pneumonia has increased in the last two months and now seems to be slightly declining,” explained Maria Van Kerkhove, WHO technical manager for the Covid pandemic, in recent days. “We are collaborating with our clinical networks and doctors working in China to understand better antibiotic resistance, a problem around the world,” Van Kerkhove added.

The RespiVirNet surveillance bulletins of the Istituto Superiore di Sanità highlight this. Various outbreaks have been recorded in China, where the bacterium was initially reported, and France.

error: Content is protected !!